IPO Issue Details
Issue Price / Price Band₹119 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size1,200 Shares per Lot
Total Issue Size62,02,800 shares (aggregating up to ₹73.81 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital-cum-Offer for Sale
Exchange / PlatformNSE SME
IPO TypeSME
Subscription OpenTue, 25 Mar 2025
Subscription CloseThu, 27 Mar 2025
Anchor AllotmentMon, 24 Mar 2025
Basis of AllotmentFri, 28 Mar 2025
Initiation of RefundsTue, 01 Apr 2025
Credit of Shares to DematTue, 01 Apr 2025
Listing DateWed, 02 Apr 2025
UPI Mandate Deadline2025-03-27
Application & Investment Details
Retail — Min (1 Lots)₹1,42,800 — 1,200 shares
Retail — Max (13 Lots)₹1,856,400 (13 Lots)
HNI — Min (2 Lots)₹2,85,600 — 2,400 shares
EPS (Pre-IPO)₹9.76
EPS (Post-IPO)₹8.35
P/E Ratio (Pre-IPO)12.19x
P/E Ratio (Post-IPO)14.25x
Net Offer to Public58,90,800 shares (aggregating up to ₹70.10 Cr)
Reserved for Market Maker3,12,000 shares (aggregating up to ₹3.71 Cr)
Pre-IPO Promoter Holding1,91,26,500 shares
Post-IPO Promoter Holding2,33,30,100 shares
Fresh Issue Shares38,91,600 shares (aggregating up to ₹46.31 Cr)
Offer for Sale Shares19,99,200 shares of ₹10 (aggregating up to ₹23.79 Cr)
About Shri Ahimsa Naturals Ltd
Incorporated in 1990, Shri Ahimsa Naturals Limited extracts and manufactures Caffeine Anhydrous, Green Coffee Bean Extracts, and Crude Caffeine, also trading other herbal extracts.The company's products find its application in the food & beverage, nutraceuticals, cosmetics and pharmaceutical industries due to their health benefits.The company's product portfolio includes the following:-Natural Caffeine:Extracted from seeds of various plants like coffee and tea, their caffeine is used in energy drinks, soft drinks, cosmetics, and pharmaceuticals.Green Coffee Bean Extract:Sourced from unroasted green coffee seeds, this extract is rich in chlorogenic acid, known for its antioxidant properties and potential weight loss benefits.The company exports its products to the USA, Germany, South Korea, the UK, Thailand, etc.For the period ending September 30, 2024, revenue from exports (including deemed exports) of the Company’s products was ₹3,530.91 lakhs, ₹7,463.71 lakhs, and ₹9,988.01 lakhs for Fiscal 2023 and ₹5,633.50 lakhs for Fiscal 2022.The manufacturing unit is situated in Jaipur, Rajasthan.The manufacturing facility complies with 2015 [Quality Management System], 2018 ISO 22000 [Food Safety Management System], 2018 ISO 45001 [Occupational Health & Safety Management System], 2015 ISO 14001 [Environmental Management System], HACCP, and GMP guidelines for superior quality.As of March 2025, the company employed about 80 employees.Competitive Strength:Experienced Promoters and Management Team.Manufacturing facility supported by technology-driven process and R&D capabilities.Long term relationship with the clients.
Objects of the Issue
Shri Ahimsa Naturals Ltd proposes to utilise the net proceeds from the Issue for the following objects:
1
Investment in our Wholly-Owned Subsidiary, Shri Ahimsa Healthcare Private Limited (SAHPL) for setting up a manufacturing unit at Sawarda, Jaipur, Rajasthan
35.00
2
General Corporate Purposes
Shareholding & Lock-in
Pre-IPO Promoter Holding
1,91,26,500 shares
Post-IPO Promoter Holding
2,33,30,100 shares